NM_018109.4:c.1643A>C
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_018109.4(MTPAP):c.1643A>C(p.Lys548Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000768 in 1,614,246 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_018109.4 missense
Scores
Clinical Significance
Conservation
Publications
- mitochondrial diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- spastic ataxia 4Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152254Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000159 AC: 40AN: 251414 AF XY: 0.000228 show subpopulations
GnomAD4 exome AF: 0.0000821 AC: 120AN: 1461874Hom.: 1 Cov.: 31 AF XY: 0.000113 AC XY: 82AN XY: 727238 show subpopulations
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152372Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74520 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:2
This sequence change replaces lysine, which is basic and polar, with threonine, which is neutral and polar, at codon 548 of the MTPAP protein (p.Lys548Thr). This variant is present in population databases (rs372986653, gnomAD 0.09%). This variant has not been reported in the literature in individuals affected with MTPAP-related conditions. ClinVar contains an entry for this variant (Variation ID: 447742). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is higher than would generally be expected for pathogenic variants in this gene. (http://gnomad.broadinstitute.org) Polyphen and MutationTaster predict this amino acid change may be benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at